NCT04776954

Brief Summary

The purpose of the study is to compare the effectiveness of resistive blanket warming to forced air warming in maintaining body temperature in participants undergoing renal transplantation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable surgery

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 2, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

September 27, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 17, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 17, 2022

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

September 27, 2024

Completed
Last Updated

September 27, 2024

Status Verified

September 1, 2024

Enrollment Period

1.1 years

First QC Date

February 25, 2021

Results QC Date

April 22, 2024

Last Update Submit

September 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • AUC of Temperature vs Time

    Outcome is reported as the Area Under Curve (AUC) of temperature vs time curve during hypothermia (core temperature less than 36 degrees Celcius) during the duration of surgery. Unit of measure is degrees Celsius per minute. Time during surgery spent under 36 degrees Celsius through comparison of nasopharyngeal temperature, which is measured by placing a nasopharyngeal temperature probe 10 to 20 cm into the nare, between forced air warming system (FAWS) and resistive blanket warming system (RBWS).

    up to 5 hours

Secondary Outcomes (1)

  • Body Temperature Upon Arrival in PACU

    up to 2 hours

Study Arms (2)

Forced Air Warming System

ACTIVE COMPARATOR

Participants in this arm will receive warming using a forced air warming system.

Device: Forced Air Warming System

Resistive Blanket Warming System

ACTIVE COMPARATOR

Participants in this arm will receive warming using a resistive blanket warming system.

Device: Resistive Blanket Warming System

Interventions

The forced air warming system has a heater unit that blows air through a conduit to an "air blanket" that inflates with forced air that circulates throughout the blanket, and exits through tiny perforations on the patient-side of that blanket. The heat primarily warms the subject through convective means. As the warmed air escapes through the perforations in the blanket, it creates an environment of continuously circulating warm air that is in contact with the skin.

Forced Air Warming System

This blanket is equivalent to an operating-room-safe electric blanket. Through a power cord, a separate power source powers a semiconductor layer within the resistive blanket to generate heat. The heat primarily warms the subject by conductive warming through direct skin contact, and, secondarily, by warming the air around the participant in areas where there is no direct skin contact.

Resistive Blanket Warming System

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Undergoing elective renal transplantation

You may not qualify if:

  • Previous surgery involving organ transplantation or nephrectomy. These patients are at higher risk of blood loss, making temperature regulation subject to more variables outside our control.
  • End stage renal disease with decreased or no urine output from normal. Bladder temperature will not be valid in these patients.
  • Previous upper extremity amputations
  • Ongoing sepsis or other infection
  • Thyroid dysfunction
  • Emergency surgery
  • Refusal of consent to participate in study
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55455, United States

Location

MeSH Terms

Conditions

Body Temperature Changes

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Michael Todd
Organization
University of Minnesota

Study Officials

  • Cole Bennett, MD

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2021

First Posted

March 2, 2021

Study Start

September 27, 2021

Primary Completion

November 17, 2022

Study Completion

November 17, 2022

Last Updated

September 27, 2024

Results First Posted

September 27, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations